X
    學術可視化工作室RC   登錄   提交文稿
學術英文編修

Frontiers in Pharmacology

期刊標題檢索 FRONT PHARMACOL 最新評論: Manuscript Deadline 05/16/2025 (2024-11-04)


期刊名稱:   ISSN:   主題領域:   影響因子範圍: -
索引:   類別:   開放訪問:   排序方式:

[Frontiers in Pharmacology]您好,您是該頁面的第 502329 位訪客。

期刊簡介
期刊名稱Frontiers in Pharmacology Frontiers in Pharmacology
LetPub Score
7.8
52 ratings
Rate

Reputation
8.2

Influence
7.2

Speed
8.4

期刊簡稱FRONT PHARMACOL
ISSN1663-9812
h-index62
CiteScore
CiteScoreSJRSNIPCiteScore Rank
7.801.0660.999
Subject fieldQuartilesRankPercentile
Category: Medicine
Subcategory: Pharmacology (medical)
Q141 / 272
Category: Medicine
Subcategory: Pharmacology
Q176 / 313

自引率 (2023-2024)4.50%自引率趨勢
掲載範囲
Frontiers in Pharmacology is a leading journal in its field, publishing rigorously peer-reviewed research across disciplines, including basic and clinical pharmacology, medicinal chemistry, pharmacy and toxicology. Field Chief Editor Heike Wulff at UC Davis is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
官方網站http://journal.frontiersin.org/journal/pharmacology
在線稿件提交http://www.frontiersin.org/submission/submissioninfo.aspx
開放訪問Yes
出版商Frontiers Media S.A.
主題領域PHARMACOLOGY & PHARMACY
出版國/地區SWITZERLAND
發行頻率
創刊年0
每年文章數2944每年文章數趨勢
黃金OA百分比99.61%
OA Related Info
APC: Yes( USD3295; )
APC waiver:Check Notes
Other charges: No
Keywords: pharmacology、pharmaceutics、ethnopharmacology、experimental pharmacology、neuropharmacology
Useful LinksAims & ScopeAuthor InstructionsEditorial BoardAnonymous peer review
Web of Science 四分位
2023-2024
WOS Quartile: Q1

CategoryEditionJIF QuartileJIF RankingJIF Percentage
PHARMACOLOGY & PHARMACYSCIEQ165/354
索引 (SCI or SCIE)Science Citation Index Expanded
鏈接到PubMed Central (PMC)https://www.ncbi.nlm.nih.gov/nlmcatalog?term=1663-9812%5BISSN%5D
平均審稿時間 *來自出版商的數據:
來自作者的數據: 14 Weeks
競爭力 *來自作者的數據:
參考鏈接
相關期刊 【Frontiers in Pharmacology】CiteScore趨勢
自引率趨勢 每年文章數趨勢
作者評論
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。
  • 同一學科的期刊
  • CiteScore趨勢
  • 自引率趨勢
  • 每年文章數趨勢
  •  
    學科內的可信期刊 影響因子
    CA-A CANCER JOURNAL FOR CLINICIANSH-index: 144

    CiteScore: 873.20
    NATURE REVIEWS DRUG DISCOVERYH-index: 289

    CiteScore: 137.40
    LANCETH-index: 700

    CiteScore: 148.10
    NEW ENGLAND JOURNAL OF MEDICINEH-index: 933

    CiteScore: 145.40
    Nature Reviews Clinical OncologyH-index: 127

    CiteScore: 99.40
    Nature Reviews Disease PrimersH-index: 48

    CiteScore: 76.70
    NATURE REVIEWS CANCERH-index: 396

    CiteScore: 111.90
    NATURE REVIEWS IMMUNOLOGYH-index: 351

    CiteScore: 93.40
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONH-index: 622

    CiteScore: 48.20
    World PsychiatryH-index: 70

    CiteScore: 64.10
    學科內最受檢索的期刊 頁面查看次數
    MEDICINE645702
    BIOMATERIALS600887
    BIOMEDICINE & PHARMACOTHERAPY498655
    JOURNAL OF ETHNOPHARMACOLOGY494347
    Journal of Materials Chemistry B476178
    Frontiers in Immunology461408
    COMPUTERS IN BIOLOGY AND MEDICINE420057
    COLLOIDS AND SURFACES B-BIOINTERFACES419538
    Frontiers in Oncology415872
    Acta Biomaterialia395868
  •  

    Frontiers in Pharmacology Frontiers in Pharmacology
    明年預測:
    穩步上升 無變化 逐步下降  刷新
  •  

     
  •  

     


首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/86)
  [Frontiers in Pharmacology] 的評論撰寫評論
作者: longge99


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2024-11-04 14:19:39 評論於
Manuscript Deadline
05/16/2025
(0) 讚! | longge99

作者: longge99


領域: 医学
審稿時間: 1.0 month(s)
結果: 修改後接受


撰寫評論

2024-11-04 14:16:51 評論於
I have launched a special journal focusing on wound repair (nanomaterials, hydrogels, traditional medicine, etc.), available at: https://www.frontiersin.org/research-topics/67876/innovative-approaches-for-wound-treatment. For submissions, you can leave a message or contact us via email. Discounts are available upon request.
(0) 讚! | longge99

作者: 雾都驰海


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-26 22:16:16 評論於
May I ask what happened next? How long has it been since the external audit?
(0) 讚! | 雾都驰海

作者: Eutopia


領域: 医学
審稿時間: 2.0 month(s)
結果: 修改後接受


撰寫評論

2024-10-26 11:08:16 評論於
The submission was made on March 8th and officially accepted on October 24th, the efficiency is still good.
(0) 讚! | Eutopia

作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-26 08:49:47 評論於
Generally speaking, the review period for Frontiers in Pharmacology averages 14 weeks, which is indeed quite long. You can wait a little longer, but if you are really worried, it is advisable to send a polite email to inquire.
(0) 讚! | Adelaide Lawson

作者: 白薇姑娘


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-16 09:05:01 評論於
Was it rejected after resubmission?
(0) 讚! | 白薇姑娘

作者: 北风倩利


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-14 22:04:16 評論於
How long does the admission process usually take?
(0) 讚! | 北风倩利

作者: 书生思淼


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-11 16:35:40 評論於
Hello, is this additional material or a rejection?
(0) 讚! | 书生思淼

作者: 东京锐藻


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-08 22:33:04 評論於
Excuse me, where can I submit the original data? Can you please point me in the right direction?
(0) 讚! | 东京锐藻

作者: 东京锐藻


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-10-08 16:23:04 評論於
Have you solved it?
(0) 讚! | 东京锐藻

作者: 黑沙韶敏


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-24 15:34:18 評論於
I sincerely ask all friends, where should the figures, figure captions, tables, and table captions be placed in the article? In what format should the figures be uploaded? Thank you, friends.
(0) 讚! | 黑沙韶敏

作者: Adelaide Lawson


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-17 12:31:24 評論於
Review speed: 2.0
Research focus: Traditional Chinese Medicine Experience Sharing
Submitted on 6.20, rejected by editor one week later with the reason being lack of analysis of Chinese medicine ingredients and medication list.
Resubmitted on 8.16 after adding ingredient analysis as requested.
Submitted on 7.19 after adding author email communication and ** exchange as requested, and resubmitted on 7.21.
During this period, it constantly showed "reviewer were invited".
Discovered a change in editor on 8.6, with status showing ongoing.
Discovered rejection again on 8.7 ?
Currently making a final appeal and waiting.
(0) 讚! | Adelaide Lawson

作者: 螳螂若山


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-13 20:53:46 評論於
Research focus: Gastrointestinal experience sharing: Submitted at the end of August and still no editor assigned. WOC.
(0) 讚! | 螳螂若山

作者: 采珍三岁啦


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-12 20:56:27 評論於
I am also feeling anxious.
(0) 讚! | 采珍三岁啦

作者: Rod Surrey


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-04 19:24:37 評論於
Is there a layout fee?
(0) 讚! | Rod Surrey

作者: 如影卫镇


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-03 08:25:45 評論於
Review speed: 3.0 | Submission hit rate: 75.0 Experience sharing: I submitted a review article and chose Professor Zhulin as the handling editor, who was particularly friendly. I wrote the review article very carefully. There were 3 reviewers, one rejected the submission, and 2 accepted it. The suggestions provided were very helpful. A very good journal.
(0) 讚! | 如影卫镇

作者: Gladys Truman


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-09-02 11:11:01 評論於
Research focus: Traditional Chinese Medicine; Sharing experiences with traditional Chinese medicine formulas: Both reviewers gave a score of 12 in the first round of revisions, and raised many questions. Is there a good chance?
(0) 讚! | Gladys Truman

作者: 孟乐小娘子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-31 14:50:10 評論於
It's really slow.
(0) 讚! | 孟乐小娘子

作者: 一条小绿竹


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-31 13:13:49 評論於
Hello, may I ask where can I find the writing requirements for the cover letter of this magazine?
(0) 讚! | 一条小绿竹

作者: 谷香殿下


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-30 12:37:15 評論於
It's been a month, and I still haven't been assigned.
(0) 讚! | 谷香殿下

作者: 太山昌盛


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-26 23:32:56 評論於
I am also, it has been 2 months and I have not been assigned an editor.
(0) 讚! | 太山昌盛

作者: 明冠涵山


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-21 15:32:55 評論於
Review speed: 1.0 | Submission success rate: 75.0 
Experience sharing: No experience
(0) 讚! | 明冠涵山

作者: 孟乐小娘子


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-16 12:47:19 評論於
Research focus: Chinese herbal monomers; Tumor experience sharing: It has been a month and I still haven't been assigned an editor at EA.
(0) 讚! | 孟乐小娘子

作者: 一只长志呀


領域: 医学
審稿時間: 0.0 month(s)
結果: 待定&不明


撰寫評論

2024-08-11 20:29:58 評論於
Could you please tell me how long it usually takes for the editor to make a decision after both reviewers have endorsed the paper? I'm really in a hurry and need to know if it's going to be accepted for publication. Thank you so much!
(0) 讚! | 一只长志呀

作者: 洗衣液xie


領域: 医学
審稿時間: 1.0 month(s)
結果: 拒稿


撰寫評論

2024-08-08 11:38:35 評論於
Research on traditional Chinese medicine compound formula
May 24, 2020: First submission, rejected by editor after 9 days, editor requested additional analysis of Chinese medicine ingredients and two drug lists (did not see this requirement in the submission guidelines before)
July 18, 2020: Submitted again with the ingredient analysis
July 20, 2020: Resubmitted with requested email correspondence and WeChat communication between authors
July 23, 2020: Editor assigned, checked AI assistant multiple times showing "reviewer were invited"
August 4, 2020: Woke up to see that the editor had been changed back to the one who previously rejected my submission (will a resubmission after rejection always go back to the original editor? Or was I just unlucky?) and saw that it was marked as "ongoing". An hour of anxiety later, I received the rejection email
The reason given was that they no longer accept studies with a dosage greater than 1g/kg per day (for all fellow researchers of traditional Chinese medicine, is this even achievable?)
Initially thought it might have been a random excuse for rejection. However, upon further examination of the rejection email, it seems the main reason was that I used Chinese medicine granules, and the editor, being a foreign editor, may not have been familiar with what Chinese medicine granules look like? This is because the reference standards provided were all for extracts or individual components.
I have already sent an appeal email to the editorial office, but have not received a response yet.
(0) 讚! | 洗衣液xie

首頁    上一頁    1    2    3    4    5    6    7    下一頁    末頁  (頁
/86)

開始撰寫 [Frontiers in Pharmacology] 的評論:





Contact us

Contact us  

Your name*

Your email*

Your message*

Please fill in all fields and provide a valid email.

Security Code*